Calton & Associates’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
RIM
ETC
AIC
Calton & Associates's ASPI Position: Q2 2026 in Review
Calton & Associates increased its ASP Isotopes (ASPI) stake by 33% in Q2 2026, buying an estimated $20.6K and bringing the position to 14,000 shares worth $87.1K. The position accounts for 0.01% of the portfolio, ranked #416.
Calton & Associates first reported a position in ASPI in Q1 2026 and has held it in 2 quarters since. 185 funds tracked by Wall St. Rank hold ASPI as of Q2 2026.
- Calton & Associates held 14,000 shares of ASP Isotopes worth $87.1K as of Q2 2026.
- Calton & Associates bought 3,500 ASP Isotopes shares in Q2 2026, an estimated $20.6K.
- ASP Isotopes made up 0.01% of Calton & Associates's portfolio in Q2 2026, its #416 holding.
- Calton & Associates first reported a position in ASP Isotopes in Q1 2026 and has held it in 2 quarters since.
- 185 funds tracked by Wall St. Rank held ASP Isotopes as of Q2 2026.
Based on Calton & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.